2021 Volume 30 Issue 2 Pages 145-152
Automated Breast Ultrasound System, ABUS) has been developed as a supplemental breast imaging tool for dense breast women. A huge amount of whole breast scanned images are sent to the reading station where a breast imager interprets and reports a huge volume of images, which brings about each reader's unexpected stresses from longer reading time as well as uneasiness about accuracy. Intense needs for appropriate solution has been claimed by breast imagers in vain. This paper was edited prioritizing the readers' familiarity with QviewCAD™ System. (abbreviated as QVCAD) for correct and better comprehension as well as the top level of QVCAD's performances. 1. Comprehensible close investigation of histories of developments of ABUS and QVCAD, to learn when and how both were interlocked and/or synchronized. 2. Learning from valuable experiences presented by Dr. Ian Grady (Director of North Valley Breast Clinic, Redding, CA. USA), profound understanding by graphic visualization of effects of ABUS as well as QVCAD so that more readers feel stronger affinity especially with QVCAD. 3. Introduction of high level of integrity of QVCAD and stunning user interface named as C-thru? Navigator. 4. Performance of QVCAD in terms of shortening of interpretation time and achievements of high levels of diagnostic accuracy are all referred from world's top-level journals as well as presentations by key opinion leaders. Timely new movements taking place in 2021, such as US FDA's decision of downgrading QVCAD's level, from class 3 (PMA) to class 2 (510k), which may influence Japan's PMDA. In Japan, new governmental actions such as foundation of the Digitalization Agency, AI Hospital Concept by Cabinet Office, and so on. “ABUS with QVCAD New Era” is now getting closer.